It’s really exciting technology that opens up a wide array of pathways for exploration. We can identify new genes that are required for the virus to replicate and determine which genetic mutations make an individual resistant to HIV infection.
Intriguing finding has scientific community abuzz
In a novel approach to conquering HIV, amfAR, The Foundation for AIDS Research, is pairing HIV researchers with bioengineers to address the main barrier to a cure for HIV: the persistent reservoirs of virus not cleared by antiretroviral therapy. A new round of Investment grants, totaling $1.2 million, will support six new research projects aimed at bringing to bear highly advanced technologies that until recently might have belonged in the pages of a science fiction novel.
Scientists at Case Western Reserve University School of Medicine have received $2.5 million from the pharmaceutical company Gilead Sciences to test two never-before-combined HIV treatments on patients.
Gene therapy — which involves modifying genetic material, such as DNA and RNA — holds exciting potential as a cure for numerous diseases and conditions, including HIV.
In February, amfAR awarded the first round of new Innovation Grants designed to spur innovation by supporting novel ideas based on limited preliminary data.